---
title: "LB Pharmaceuticals (LBRX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/LBRX.US/norm.md"
symbol: "LBRX.US"
name: "LB Pharmaceuticals"
parent: "https://longbridge.com/en/quote/LBRX.US.md"
datetime: "2026-03-16T11:27:04.739Z"
locales:
  - [en](https://longbridge.com/en/quote/LBRX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/LBRX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/LBRX.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/LBRX.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/LBRX.US/norm.md)


# LB Pharmaceuticals (LBRX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1406 | -20.21 | -20.21 | -38.23 | - |
| ROE | -13.79% | 19.59% | - | - | - |
| Revenue | - | - | - | - | - |
| Net income | -3.56M | -5.09M | -5.09M | - | -14.18M |
| Operating income | -5.25M | -5.29M | -5.29M | - | -16.08M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 320.75M | 19.25M | 19.25M | - | - |
| Leverage | 1.03 | 1.85 | 1.85 | - | - |
| BVPS | 12.26 | -412.54 | -412.54 | - | - |
| Turnover | - | - | - | - | - |
| Cash & STI | 314.48M | 14.22M | 14.22M | - | - |
| Inv & Rec | - | - | - | - | - |
| LT assets | 3.83M | 3.96M | 3.96M | - | - |
| Net debt | -310.81M | -10.46M | -10.46M | - | - |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -3.37M | -6.87M | -6.87M | -13.85M | -22.04M |
| Investing CF | -44.84M | 2.49M | 2.49M | - | 28.87M |
| Financing CF | 303.73M | - | - | - | 20000.00 |
| Free CF | -941750.00 | -2.75M | - | -5.45M | - |
| OCF coverage | - | -114433.33% | -114433.33% | -4067.84% | -4974.49% |
| Repaid & issued | - | - | - | - | - |
| CapEx | 0.0000 | -6000.00 | -6000.00 | -340500.00 | -443000.00 |